The AI in oncology market is estimated to grow from USD 1.7 billion in 2024 to reach USD 2.4 billion in 2025 and USD 9.1 billion by 2035, representing a higher CAGR of 14.1% during the forecast period. Further, more than 35 million new cancer cases are likely to be diagnosed by 2050. According to the International Agency for Cancer Researchers, the number of cancer-associated deaths is likely to increase by 72%, by 2030. In February 2025, Myriad Genetics signed a strategic partnership with PATHO...

The vaccine development companies produced an estimated 7 billion doses of vaccines globally, in the year 2024 and are expected to produce around 8 billion doses in 2025. In January 2025, the Coalition for Epidemic Preparedness Innovations (CEPI) has made a significant new investment of $ 24 million in the Vaccine and Infectious Disease Organization (VIDO), aiming to bolster global preparedness for future infectious disease outbreaks as the world continues to recover from the last pandemic. Nota...

The targeted protein degradation market is estimated to grow from USD 0.48 billion in 2024 to reach USD 1.00 billion in 2025 and USD 6.94 billion by 2035, representing a higher CAGR of 21% during the forecast period. In June 2025, SEED Therapeutics announced the appointment of Dr. Bill Desmarais as the Chief Financial Officer and Chief Business Officer, who previously served as Chief Business Officer at Alchemab Therapeutics. In May 2025, Kesmalea Therapeutics appointed Tim Clackson to its board...

The biostimulants market is estimated to grow from USD 2.88 billion in 2024 to reach USD 3.18 billion in 2025 and USD 8.60 billion by 2035, representing a higher CAGR of 10.45% during the forecast period. The farm bill describes biostimulants as substances or microorganisms that stimulate natural processes to enhance nutrient uptake, nutrient efficiency, tolerance to abiotic stress, or crop quality and yield. In May 2025, TPG and Renaissance Partners jointly acquired a stake in SICIT. An Italy-...

Several market players are focusing on strategic initiatives to strengthen their product portfolio and expand innovation. For instance, in January 2025, Bayer Consume Health (Germany) launched, CanesMeno®, a unique science-backed product range and defined digital education resources crafted by the experts for the first time in the UK. The product is specifically designed to support health of 13 million women in the UK who are experiencing menopausal / premenopausal condition. Similarly, a lot o...

The global digital therapeutics market, valued at USD 3.53 billion in 2025, is projected to reach USD 4.47 billion in 2026 and USD 19.76 billion by 2035, with a 17.94% CAGR during the forecast period 2026 to 2035. With regards to type of therapy, the curative segment dominates the global market with 85% of the market share. Based on the purpose of solution, the medication replacement solutions segment holds the largest market share (nearly 65%). With respect to type of business model, B2B seg...

The global AAV vector market, valued at USD 3.0 billion in 2025, is projected to reach USD 3.7 billion in 2026 and USD 10.8 billion by 2035, representing a CAGR of 13% during the forecast period 2026 to 2035. In terms of type of manufacturer, contract manufacturer segment is estimated to capture majority of the AAV vector manufacturing market share, and this trend is unlikely to change in the future as well. In April 2026, FDA approved Otarmeni, the first dual adeno-associated virus vector-based...

The global vocal biomarkers market, valued at USD 2.56 billion in 2024, is projected to reach USD 2.98 billion in 2025 and USD 10.49 billion by 2035, with a CAGR of 13.4% during the forecast period 2025 to 2035. This market is growing steadily, driven by the growing recognition of voice analysis for disease diagnosis and monitoring. In terms of disease indication, neurological disorders segment currently holds over 70% of the market share due to the increasing usage of voice analysis for detecti...

The continuous manufacturing market valued at USD 2,599 million in 2025, is project to reach USD 2,847 million in 2026 and USD 4,193 million by 2035, representing a CAGR of 4.4% during the forecast period 2026 to 2035. This continuous process minimizes downtime and maximizes equipment utilization, leading to higher efficiency and productivity, reduced unit costs (around 40-50%), and expediated drug commercialization. Amongst the publicly revealed partnerships and collaborations in the continuous...

The Alzheimer’s disease market is estimated to grow from USD 11.3 billion in 2024 to reach USD 12.4 billion in 2025 and USD 29.4 billion by 2035, representing a higher CAGR of 9% during the forecast period. As per the data provided by the Alzheimer's Association, over 7 million Americans are currently suffering from Alzheimer's disease. Further, the cases are likely to reach nearly 13 million by 2050. In June 2025, Cure Parkinson and Alzheimer’s Research UK entered into a strategic partnersh...

The global biotherapeutics market, valued at USD 481 billion in 2025, is projected to reach USD 528 billion in 2026 and USD 1,048 billion by 2035, with a 7.9% CAGR during the forecast period 2026 to 2035. Biotherapeutics industry is anticipated to witness upward trajectory owing to the growing shift towards biologics for treating wide range of diseases, including cancer, infectious diseases, and autoimmune disorders. The recent USFDA accelerated approval of AbbVie's Emrelis™ (telisotuzumab ved...

The global veterinary regenerative medicine market size, valued at USD 388 Million in 2025, is projected to reach USD 437 Million in 2026 and USD 1,189 Million by 2035, representing a CAGR of 11.8% during the forecast period. In terms of product, stem cell therapies is securing 53% of the market share driven by the widespread adoption of these therapies to treat wounds, damages tissues and chronic conditions. With regards to end user, the veterinary hospitals / clinics segment holds the highest...

The global regenerative medicine for spinal cord market size, valued at USD 16 million in 2025, is projected to reach USD 54 million in 2026 and USD 655 million by 2035, representing a CAGR of 32% during the forecast period, 2026 to 2035. The growth in the market is driven by strong scientific progress, expanding clinical trial activity, and increasing investment in advanced therapies such as stem cells and gene-based approaches. The global market for regenerative medicine for spinal cord injuri...

The global nasal drug delivery market, valued at USD 6.1 billion in 2025, is projected to reach USD 8.1 billion in 2026 and USD 26.8 billion by 2035, with a 14.2% CAGR during the forecast period 2026 to 2035. The global market highlights the market segmentation of nasal drug delivery, based upon their target indication into acute repetitive clusters, anaphylaxis, COVID-19, dry eye disease, hypoglycemia, influenza, major depressive disorder, migraine, nasal polyps, and prader-willi syndrome.

The global AI in skincare market, valued at USD 1.19 billion in 2024, is projected to reach USD 1.37 billion in 2025 and USD 4.28 billion by 2035, with a CAGR of 12.1% during the forecast period. This market is growing due to the growing adoption of AI algorithm for skin analysis to prepare personalized skincare solutions. In August 2025, Debut (US) raised USD 20 million to accelerate the expansion of its AI-based ingredient discovery platform to enhance innovation in skin longevity. Kult (India...

The global needles market size is projected to grow from $8.1 billion in 2025 to $14.7 billion by 2035, representing a CAGR of 6.1% during the forecast period. Over the years, the incidence of chronic conditions, such as diabetes, autoimmune diseases, heart diseases, and cancer has risen significantly. The conventional needle segment holds majority of the shares (69%) in the current market. However, this percentage distribution is likely to change during the forecast period, till 2035. Over 475...

The global digital age skincare market, valued at USD 66 billion in 2025, is projected to reach USD 78 billion in 2026 and USD 321 billion by 2035, with a CAGR of 17% during the forecast period 2026 to 2035. In August 2025, Revive (US) launched AI-powered skin diagnostic solution to deliver more advanced and personalized skincare solutions based on individuals requirements. In June 2025, Skin-Pal (Tiawan) launched “Skin Beauty Pal”, an AI-powered skin analysis app in Indian skincare market a...

The global AI in animal health market, valued at USD 1.68 billion in 2025, is projected to reach USD 2.00 billion in 2026 and USD 8.87 billion by 2035, with a CAGR of 18.0% during the forecast period 2026 to 2035. For instance, in October 2025, the Independent Animal Health Association (IAHA, US) entered into the partnership with ScribbleVet (US) to provide access to advanced AI technology in veterinary medicine across more than 650 independently owned veterinary hospitals to enhance animal care...

The flow cytometry services market, valued at USD 3.74 billion in 2025, is projected to reach USD 4.10 billion in 2026 and USD 9.23 billion by 2035, with a 9.44% CAGR during the forecast period 2026 to 2035. High demand of flow cytometry analysis for various applications in the medical industry, coupled with stringent regulatory guidelines, has driven the need for advanced flow cytometry services that enable rapid, accurate, and high-throughput analysis of cell populations.

The global clinical trial lab services market, valued at USD 4.99 billion in 2025, is projected to reach USD 5.42 billion in 2026 and USD 10.68 billion by 2035, with a CAGR of 7.8% during the forecast period 2026 to 2035. In September 2025, Global Clinical Central Lab (GCCL, South Korea), and Frontage Laboratories (US) signed a strategic Memorandum of Understanding agreement to strengthen their presence in global clinical market. Under this agreement, GCCL also leverage the complementary clinica...